Source: Annual Congress 2010 - Special treatment options in tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Cojocariu, A. Sorete Arbore, R. Sorete Arbore, T. Mihaescu (Iasi, Romania). Risk factors for failure in pulmonary TB new cases-10 years review. Eur Respir J 2010; 36: Suppl. 54, 3129

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and risk factors for pulmonary aspergillosis infection in thoracic oncology: a 5 years retrospective study Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Misdiagnosed pulmonary TB: Influencing factors and diagnostic chances in TB hospital Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 The assessment of risk factors and treatment of pulmonary TB relapses Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006 Risk factors associated with death in pulmonary tuberculosis Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Risk factors of pulmonary NTM disease in COPD: how bad are glucocorticoids? Source: International Congress 2014 – The rise in non-tuberculous mycobacteria (NTM) pulmonary diseases Year: 2014 Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study Source: Eur Respir J, 55 (1) 1900798; 10.1183/13993003.00798-2019 Year: 2020 Predictors of mortality in otherwise healthy patients with pulmonary tuberculosis: A retrospective cohort study Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001 A prediction rule to stratify mortality risk of patients with pulmonary tuberculosis Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016 Risk factors for pulmonary Mycobacterium avium-intracellulare complex disease deterioration in immunocompetent patients Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 The influence of the epidemic risk factor on advanced processes in adolescents with newly-detected pulmonary TB Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007 Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding Source: Eur Respir J 2013; 41: 462-468 Year: 2013 Risk factors for respiratory failure in patients with COVID-19 pneumonitis: A retrospective study Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021 Risk factors for tuberculosis in patients with chronic alcoholism Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Pulmonary tuberculosis relapse: predisposing factors and management in Tunisia Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Risk factors and outcome in pulmonary nocardiosis Source: Eur Respir J 2002; 20: Suppl. 38, 353s Year: 2002 Characteristics and risk factors for missed pulmonary tuberculosis Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020